fda approves semaglutide for cardiovascular risk reduction Wegovy to Reduce Heart Disease and Stroke in People With Obesity FDA approves weight-loss drug Wegovy

Given that the food environments people live in make it difficult to make healthy choices, I believe that this move will only meaningfully benefit the health of all Americans if it is combined with other policy changes

No published controlled trial has studied combining tirzepatide and retatrutide in humans

Its still semaglutide

Osmotic diarrhea, severe flatulence, and abdominal cramps will come to you right away

By week 8, most patients can expect to see 5-10 pounds of weight loss, though this varies based on starting weight, metabolism, and adherence to healthy eating patterns

Other effects such as redness and itching at injection sites, increased resting heart rate, and rare but serious risks like pancreatitis make close monitoring and careful meal selections important